Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer.
Marhelava K, Pilch Z, Bajor M, Graczyk-Jarzynka A, Zagozdzon R. Marhelava K, et al. Cancers (Basel). 2019 Nov 8;11(11):1756. doi: 10.3390/cancers11111756. Cancers (Basel). 2019. PMID: 31717326 Free PMC article. Review.
Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors.
Bobrowicz M, Slusarczyk A, Domagala J, Dwojak M, Ignatova D, Chang YT, Iselin C, Miazek-Zapala N, Marhelava K, Guenova E, Winiarska M. Bobrowicz M, et al. Among authors: marhelava k. Oncol Lett. 2020 Jul;20(1):533-540. doi: 10.3892/ol.2020.11587. Epub 2020 May 6. Oncol Lett. 2020. PMID: 32565979 Free PMC article.
Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells.
Bajor M, Graczyk-Jarzynka A, Marhelava K, Kurkowiak M, Rahman A, Aura C, Russell N, Zych AO, Firczuk M, Winiarska M, Gallagher WM, Zagozdzon R. Bajor M, et al. Among authors: marhelava k. Antioxidants (Basel). 2020 Apr 16;9(4):320. doi: 10.3390/antiox9040320. Antioxidants (Basel). 2020. PMID: 32316111 Free PMC article.